Moderna Japan Announces Appointment of New Representative Director and President
NQ Score
63/100
AI Summary (NQ-processed)
Moderna Japan announced the appointment of Kei Kaneda as its new Representative Director and President, effective April 1, 2026.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Who is the new President of Moderna Japan?
- A: Effective April 1, 2026, Kei Kaneda, General Manager, has been appointed Representative Director and President.
- Q: What will happen to the former President, Patrick Bergstedt?
- A: He will retire from his position as Representative Director on the same date and continue to serve Moderna as Senior Vice President and General Manager, Asia & Emerging Markets.
- Q: What business areas is Moderna focusing on in Japan?
- A: Moderna is focused on delivering the value of mRNA medicines to the people of Japan, collaborating with health authorities and other stakeholders to contribute to health.